Ranbaxy Breaks Even Overseas

The overseas subsidiaries and affiliates of domestic pharmaceutical major Ranbaxy Laboratories Ltd have finally managed to break-even.

Together, the 19 subsidiaries and 2 affiliates posted a gross profit of $6.8 million on a turnover of $158.8 million during 2000, according to sources.

During 1999, the overseas subsidiaries and affiliates of Ranbaxy had clocked a loss of $2.9 million on a turnover of $118.2 million.

The overseas affiliates and subsidiaries have also cut their net loss from $6.9 million in 1999 to $1.2 million in 2000. Interestingly, the net loss of $1.2 million for 2000 is less than the net loss of $2.1 million